1. Home
  2. CTNT vs MBIO Comparison

CTNT vs MBIO Comparison

Compare CTNT & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$2.69

Market Cap

6.4M

Sector

N/A

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.66

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
MBIO
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
5.3M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
CTNT
MBIO
Price
$2.69
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
168.3M
33.8K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
98.99
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.53
52 Week High
$4.21
$7.00

Technical Indicators

Market Signals
Indicator
CTNT
MBIO
Relative Strength Index (RSI) 64.10 33.11
Support Level $1.48 $0.53
Resistance Level $4.21 $0.80
Average True Range (ATR) 0.34 0.04
MACD 0.19 -0.00
Stochastic Oscillator 64.30 10.40

Price Performance

Historical Comparison
CTNT
MBIO

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: